Generation and characterization of transgenic mice expressing mitochondrial targeted red fluorescent protein selectively in neurons: Modeling mitochondriopathy in excitotoxicity and amyotrophic lateral sclerosis

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Wang, Yi ^a   Pan, Yan ^a   Price, Ann ^a   Martin, Lee J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; amyotrophic lateral sclerosis; CA1 neuron; excitotoxicity; motor neuron; Parkinson's disease

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; RED FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN DSRED2; UNCLASSIFIED DRUG; LUMINESCENT AGENT; PHOTOPROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN STEM; CELL DEATH; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EMBRYO; EXCITOTOXICITY; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOBLOTTING; MALE; MITOCHONDRION; MOTONEURON; MOUSE; NERVE CELL; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; THALAMUS; ANIMAL; BRAIN; CELL LINE; DISEASE MODEL; GENETICS; HISTOLOGY; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANTHOZOA; DISCOSOMA SP.; MUS; MUS MUSCULUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BRAIN; CELL LINE; DISEASE MODELS, ANIMAL; HUMANS; LUMINESCENT AGENTS; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NEURONS; RECOMBINANT FUSION PROTEINS;

EID: 80055111693     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-75     Document Type: Article

References (51)

1. Mutation in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Zuchner S, Meriyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, et al. Nat Gen 2004 36 449 451 (Pubitemid 38620027)
2. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn of evolutionary medicine. Wallace DC, Annu Rev Genet 2005 39 359 407 (Pubitemid 43011120)
3. Abnormal mitochondrial dynamics and neurodegenerative diseases. Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X, Biochim Biophy Acta 2010 1802 135 142
4. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Reddy PH, Beal MF, Trends Mol Med 2008 14 45 53
5. Free radical damage, iron, and Alzheimer's disease. Smith MA, Perry G, J Neurol Sci 1995 134 Suppl 92 94
6. Mitochondrial and cell death mechanisms in neurodegenerative diseases. Martin LJ, Pharmaceuticals 2010 3 839 915
7. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, Geuskens M, Kroemer G, Oncogene 1997 15 1573 1581 (Pubitemid 27464650)
8. The mitochondrion as Janus Bifrons. Zorov DB, Isave NK, Plotnikov EY, Zorova LD, Stelmashook EV, Vasileva AK, Arkhagelskaya AA, Khrjapenkova TG, Biochemistry (Moscow) 2007 72 1115 1126 (Pubitemid 350022593)
9. Inhibition of bax channel-forming activity by bcl-2. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod J-J, Mazzei G, Maundrell K, Gambale F, Sadoul R, Martinou J-C, Science 1997 277 370 372 (Pubitemid 27450709)
10. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HL, Prévost MC, Xie Z, Matsuyama S, Reed JC, Kroemer G, Science 1998 281 2027 2031 (Pubitemid 28475490)
11. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. Shimizu S, Ide T, Yanagida T, Tsujimoto Y, J Biol Chem 2000 275 12321 12325 (Pubitemid 30237814)
12. The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation. Martin LJ, Adams NA, Pan Y, Price A, Wong M, J Neurosci 2011 31 359 370
13. The fluorescent protein color palette. Olenych SG, Claxton NS, Ottenberg GK, Davidson MW, Cur Protoc Cell Biol 2007 21.5 1 34
14. 'Green mice' as a source of ubiquitous green cells. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y, FEBS Lett 1997 407 313 9 (Pubitemid 27199450)
15. 2+ signals in situ and in vivo. Atkin SD, Patel S, Kocharyan A, Holtzclaw LA, Weerth SH, Schram V, Pickel J, Russell JT, J Neurosci Meth 2009 181 212 226
16. An approach to experimental synaptic pathology using green fluorescent protein-transgenic mice and gene knockout mice to show mitochondrial permeability transition pore-driven excitotoxicity in interneurons and motoneurons. Martin LJ, Toxicol Pathol 2011 39 220 233
17. Directed differentiation of embryonic stem cells into motor neurons. Wichterle H, Lieberam I, Porter JA, Jessell TM, Cell 2002 110 385 97
18. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, nerbonne JM, Lichtman JW, Sanes JR, Neuron 2000 28 41 51
19. Adult olfactory bulb neural neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. Martin LJ, Liu Z, J Neuropathol Exp Neurol 2007 66 1002 1018 (Pubitemid 350060368)
20. Novel hippocampal interneuronal subtypes identified using transgenic mice that express green fluorescent protein in GABAergic interneurons. Oliva AA, Jiang M, Lam T, Smith KL, Swann JW, J Neurosci 2000 20 3354 68 (Pubitemid 30263151)
21. Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. Zeilhofer HU, Studler B, Arabadzisz D, Schweizer C, Ahmadi S, Layh B, Bosl MR, Fritschy J-M, J Comp Neurol 2005 482 123 41 (Pubitemid 40066644)
22. Control of mitochondrial shape. Jensen RE, Curr Opin Cell Biol 2005 17 384 388 (Pubitemid 40968068)
23. Lincreases mitochondrial fission, fusion, and biomass in neurons. Berman SB, Chen Y-b, Qi B, McCaffery JM, Rucker EB III, Goebbels S, Nave K-A, Arnold BA, Jonas EA, Pineda FJ, Hardwick JM, J Cell Biol 2009 184 707 719
24. Mitochondrial trafficking in neurons: a key variable in neurodegeneration? Reynolds IJ, Mlaiyandi LM, Coash M, Rintoul GL, J Bioenerg Biomemb 2004 36 283 286 (Pubitemid 39619827)
25. Lamellar organization of hippocampal excitatory pathways. Anderson P, Bliss TVP, Skrede KK, Exp Brain Res 1971 13 222 238
26. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis. Chang Q, Martin LJ, J Neurosci 2011 31 2815 2827
27. Motoneuron subtypes show specificity in glycine receptor channel abnormalities in a transgenic mouse model of amyotrophic lateral sclerosis. Chang Q, Martin LJ, Channels 2011 5 1 5
28. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Science 1994 264 1772 1775 (Pubitemid 24227760)
29. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. Martin LJ, Liu Z, Chen K, Price AC, Pan Y, Swaby JA, Golden WC, J Comp Neurol 2007 500 20 46 (Pubitemid 44904300)
30. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Martin LJ, Gertz B, Pan Y, Price AC, Molkentin JD, Chang Q, Exp Neurol 2009 218 33 346
31. Emerging functions of mammalian mitochondrial fusion and fission. Chen H, Chan DC, Hum Mol Genet 2005 14 283 R289
32. A noncytotoxic DsRed variant for whole-cell labeling. Strack RL, Strongin DE, Bhattacharyya D, Tao W, Berman A, Broxmeyer HE, Keenan RJ, Glick BS, Nat Methods 2008 5 955 957
33. Overexpression of growth-associated proteins in neurons of adult transgenic mice. Caroni P, J Neurosci Meth 1997 71 3 9 (Pubitemid 27145767)
34. Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Rizzuto R, Brini M, Pizzo P, Murgia M, Pozzan T, Curr Biol 1995 5 635 642
35. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. Wang X, Su B, Lee H-g, Li X, Perry G, Smith MA, Zhu X, J Neurosci 2009 29 9090 9103
36. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Wong-Riley MTT, Trends Neurosci 1989 3 94 101 (Pubitemid 19067056)
37. Neuron-specific conditional expression of a mitochondrially targeted fluorescent protein in mice. Chandrasekaran K, Hazelton JL, Wang Y, Fiskum G, Kristian T, J Neurosci 2006 26 13123 13127 (Pubitemid 46011623)
38. Imaging axonal transport of mitochondria in vivo. Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW, Nat Meth 2007 4 559 561 (Pubitemid 47214773)
39. Global imaging of mitochondrial morphology in tissues using transgenic mice expressing mitochondrially targeted enhanced green fluorescent protein. Shitara H, Shimanuki M, Hayashi J-I, Yonekawa H, Exp Anim 2010 59 99 103
40. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, Braga M, Silani V, De Biasi S, J Neurol Sci 2001 191 25 33 (Pubitemid 33035892)
41. Parkinson's disease -synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK, J Neurosci 2006 26 41 50 (Pubitemid 43089519)
42. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR, Biomol Eng 2001 17 157 165 (Pubitemid 32409891)
43. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. Lino MM, Schneider C, Caroni P, J Neurosci 22 4825 4832 202
44. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, Rothstein JD, Griffin J, Price DL, Martin LJ, Wong PC, J Neurosci 2008 28 1997 2005 (Pubitemid 351317634)
45. Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP, Dev Dyn 1992 194 209 221
46. Epigenetic regulation of motor neuron cell death through DNA methylation. Chestnut BA, Chang Q, Lesuisse C, Wong M, Martin LJ, J Neurosci 2011
47. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Arber S, Han B, Mendelsohn M, Smith M, Jessell TM, Sockanathan S, Neuron 1999 23 659 674 (Pubitemid 29411557)
48. Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9. Thaler J, Harrison K, Sharma K, Lettieri K, Kehrl J, Pfaff SL, Neuron 1999 23 675 687 (Pubitemid 29411558)
49. Early events of target deprivation/axotomy-induced neuronal apoptosis in vivo: oxidative stress, DNA damage, p53 phosphorylation and subcellular redistribution of death proteins. Martin LJ, Price AC, McClendon KB, Al-Abdulla NA, Subramaniam JR, Wong PC, Liu Z, J Neurochem 2003 85 234 247 (Pubitemid 36389713)
50. Visualization of xenotransplanted human rhabdomyosarcoma after transfection with red fluorescent protein. Seitz G, Warmann SW, Fuchs J, Mau-Holzmann UA, Ruck P, Heitmann H, Hoffman RM, Mahrt J, Muller GA, Wessels JT, J Ped Surg 2006 41 1369 1376 (Pubitemid 44080245)
51. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Chen K, Northington FJ, Martin LJ, Brain Struct Funct 2010 214 219 234.